Close Menu

This article has been updated with additional information from Foundation Medicine.

NEW YORK (GenomeWeb) – The US Food and Drug Administration has approved Foundation Medicine's NGS-based genomic profiling test, FoundationOne CDx (F1CDx), the agency said today. Concurrently, the Centers for Medicare and Medicaid Services (CMS) issued a preliminary national coverage determination for the test and others like it.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.